1. Home
  2. BLND vs PLSE Comparison

BLND vs PLSE Comparison

Compare BLND & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLND
  • PLSE
  • Stock Information
  • Founded
  • BLND 2012
  • PLSE 2014
  • Country
  • BLND United States
  • PLSE United States
  • Employees
  • BLND N/A
  • PLSE N/A
  • Industry
  • BLND EDP Services
  • PLSE Medical/Dental Instruments
  • Sector
  • BLND Technology
  • PLSE Health Care
  • Exchange
  • BLND Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • BLND 946.9M
  • PLSE 1.2B
  • IPO Year
  • BLND 2021
  • PLSE 2016
  • Fundamental
  • Price
  • BLND $3.99
  • PLSE $23.57
  • Analyst Decision
  • BLND Buy
  • PLSE
  • Analyst Count
  • BLND 8
  • PLSE 0
  • Target Price
  • BLND $4.86
  • PLSE N/A
  • AVG Volume (30 Days)
  • BLND 2.9M
  • PLSE 127.7K
  • Earning Date
  • BLND 03-13-2025
  • PLSE 03-27-2025
  • Dividend Yield
  • BLND N/A
  • PLSE N/A
  • EPS Growth
  • BLND N/A
  • PLSE N/A
  • EPS
  • BLND N/A
  • PLSE N/A
  • Revenue
  • BLND $156,715,000.00
  • PLSE N/A
  • Revenue This Year
  • BLND $5.35
  • PLSE N/A
  • Revenue Next Year
  • BLND $20.75
  • PLSE N/A
  • P/E Ratio
  • BLND N/A
  • PLSE N/A
  • Revenue Growth
  • BLND N/A
  • PLSE N/A
  • 52 Week Low
  • BLND $2.08
  • PLSE $6.60
  • 52 Week High
  • BLND $5.53
  • PLSE $23.62
  • Technical
  • Relative Strength Index (RSI)
  • BLND 43.79
  • PLSE 59.71
  • Support Level
  • BLND $3.61
  • PLSE $17.35
  • Resistance Level
  • BLND $4.06
  • PLSE $22.05
  • Average True Range (ATR)
  • BLND 0.20
  • PLSE 1.22
  • MACD
  • BLND 0.06
  • PLSE 0.26
  • Stochastic Oscillator
  • BLND 61.38
  • PLSE 65.91

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: